High or Low Testosterone in Women: What Symptoms Mean

You can usually tell when something has shifted. Maybe it is the energy that used to carry you through Wednesday afternoons. Maybe it is mood, libido, or the way your skin breaks out in a pattern it did not have a year ago. High or low testosterone in women can feel real, but the symptoms only make sense once the surrounding markers are in view.

Female testosterone is not a small or obscure marker. Across the reproductive years, women produce testosterone in higher circulating concentrations than estradiol on a molar basis, and it influences energy, mood, sexual desire, lean muscle, skin and bone (Davis & Wahlin-Jacobsen, 2015). When the level moves meaningfully outside its typical range in either direction, the effects can show up in how you feel.

The hard part is that none of these signals belongs to testosterone alone. Sleep, thyroid function, iron status, stress, nutrition, medication and cycle timing can look similar from the outside. This article walks through both directions, what to test, and why a single number rarely answers the question. For the foundational primer on testosterone biology, the companion article on testosterone in the body covers the basics in more depth.

When testosterone runs lower than typical

Lower-than-typical testosterone in women often feels less dramatic than people expect. It can show up as a quiet drop in baseline: energy that used to feel reliable becomes harder to summon, motivation flattens, sexual desire softens, and training recovery can feel slower. The mood pattern is often described as muted rather than acutely sad.

The most important detail is that most testosterone in circulation is not free to act on tissues. A large share is bound to sex hormone-binding globulin (SHBG), and only a small unbound fraction is biologically active (Goldman et al., 2017). When SHBG runs high, which is common with combined oral contraceptives or oral estrogen exposure, total testosterone can sit within range while the available fraction is low. Combined oral contraceptives raise SHBG and lower androgen production, with free testosterone often falling more than total testosterone (Zimmerman et al., 2014).

That is why the Free Testosterone Index, calculated from testosterone and SHBG, is a better lens than total testosterone alone. The Endocrine Society guideline describes calculated free testosterone from total testosterone and SHBG as clinically sensitive in the evaluation of androgen status in women (Martin et al., 2018). A normal total testosterone result does not, by itself, rule out low androgen availability.

When testosterone runs higher than typical

Higher-than-typical readings tend to show up on the skin first. Adult-onset acne, oilier skin or new hair growth in a pattern that was not there before are common reasons people start asking about testosterone. Cycles can become less predictable. Some people notice scalp hair thinning in a more androgen-sensitive pattern. Excess male-pattern hair growth alone affects a meaningful minority of women in the general population, and the symptom is often treated cosmetically before a hormone pattern is checked (Martin et al., 2018).

Higher testosterone can come from different pathways. Dehydroepiandrosterone sulfate (DHEA-S) reflects androgen output from the adrenal glands. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) reflect pituitary signalling that drives ovarian hormone production. Reading these markers together helps separate a pattern that may be more adrenal, more ovarian, or more related to the broader cycle context. A study in young Australian women also found that body-hair scores related to androgen concentrations, which is one reason symptoms and blood markers need to be interpreted together (Skiba et al., 2020).

A wider context matters too. Female androgen excess and male androgen deficiency can share an overlapping cluster of metabolic changes, including shifts in body fat distribution and insulin sensitivity (Schiffer et al., 2017). Hormone testing is therefore useful beyond skin or cycle symptoms, but it still does not diagnose a condition on its own.

Why a single number rarely tells the whole story

Three things make female testosterone harder to interpret than a single number on a result sheet suggests.

The first is the menstrual cycle. Testosterone and androstenedione can be higher during the mid-cycle and luteal phases than in the early follicular phase, so the same woman may produce different readings on day 3 versus day 14 (Skiba et al., 2019). This is why female hormone panels are timed to days 2 to 5: the early follicular window gives a more comparable baseline. The wider question of how cycle phase affects blood test results is covered in this guide to female hormones and lab results.

The second is age. Female androgens decline measurably across the reproductive years, well before menopause, with a steep fall during the twenties and thirties (Davison et al., 2005). What counts as a typical reading at 25 is not necessarily the same as at 38, and age-specific reference ranges are still being refined (Skiba et al., 2019).

The third is SHBG. The same total testosterone value can mean different things depending on whether SHBG is high, low or typical. Without SHBG, the Free Testosterone Index cannot be calculated, and the result leaves out what your tissues may actually be exposed to.

None of this means a hormone panel diagnoses anything on its own. The leading endocrine guideline is clear that single readings should inform a clinical conversation, not replace it (Wierman et al., 2014). Testing replaces guesswork with data, so the conversation with a healthcare professional starts from your physiology rather than symptom interpretation alone.

The markers that change the conversation

A complete female hormone panel for these scenarios includes nine markers. Each plays a role, and looking at one in isolation tends to create the wrong story.

High or low testosterone in women, frequently asked